Metropolitan Life Insurance Company (MetLife)’s Minerva Neurosciences NERV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-289
| Closed | -$13.9K | – | 2573 |
|
|
2020
Q1 | $13.9K | Buy |
+289
| New | +$13.9K | ﹤0.01% | 2468 |
|
|
2019
Q4 | – | Sell |
-1,416
| Closed | -$87.8K | – | 2551 |
|
|
2019
Q3 | $87.8K | Sell |
1,416
-34
| -2% | -$2.11K | ﹤0.01% | 2367 |
|
|
2019
Q2 | $65.3K | Hold |
1,450
| – | – | ﹤0.01% | 2465 |
|
|
2019
Q1 | $91.2K | Buy |
1,450
+11
| +0.8% | +$692 | ﹤0.01% | 2365 |
|
|
2018
Q4 | $77.6K | Hold |
1,439
| – | – | ﹤0.01% | 2430 |
|
|
2018
Q3 | $145K | Hold |
1,439
| – | – | ﹤0.01% | 2225 |
|
|
2018
Q2 | $95K | Buy |
+1,439
| New | +$95K | ﹤0.01% | 2347 |
|
|
2017
Q3 | – | Sell |
-2,397
| Closed | -$170K | – | 2506 |
|
|
2017
Q2 | $170K | Buy |
+2,397
| New | +$170K | ﹤0.01% | 2432 |
|
|
2017
Q1 | – | Sell |
-2,015
| Closed | -$189K | – | 2537 |
|
|
2016
Q4 | $189K | Hold |
2,015
| – | – | ﹤0.01% | 2381 |
|
|
2016
Q3 | $227K | Buy |
+2,015
| New | +$227K | ﹤0.01% | 2255 |
|